Chapter 1 28 19. Vijgen L, Keyaerts E Fau - Moës E, Moës E Fau - Thoelen I, et al. Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event. (0022-538X (Print)). 20. Worobey M, Levy JI, Serrano LM, et al. The Huanan Seafood Wholesale Market in Wuhan was the early epicenter of the COVID-19 pandemic. Science 0(0): abp8715. 21. Zamorano Cuervo N, Grandvaux N. ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities. eLife 2020; 9: e61390. 22. Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. J Virol 2020; 94(7): e00127-20. 23. Baker T, Schell CO, Petersen DB, et al. Essential care of critical illness must not be forgotten in the COVID-19 pandemic. The Lancet 2020; 395(10232): 1253-4. 24. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA 2020; 323(13): 1239-42. 25. Lamers MM, Haagmans BL. SARS-CoV-2 pathogenesis. Nature Reviews Microbiology 2022; 20(5): 270-84. 26. Menter TA-O, Haslbauer JD, Nienhold R, et al. Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. (1365-2559 (Electronic)). 27. Montazersaheb S, Hosseiniyan Khatibi SM, Hejazi MS, et al. COVID-19 infection: an overview on cytokine storm and related interventions. Virology Journal 2022; 19(1): 92. 28. WHO. Estimating mortality from COVID-19. In: (EPP) EaPPaP. Geneva, Switzerland: World Health Organization (WHO), 2020. 29. Ahammed TA-O, Anjum AA-OX, Rahman MM, Haider NA-O, Kock R, Uddin MA-O. Estimation of novel coronavirus (COVID-19) reproduction number and case fatality rate: A systematic review and meta-analysis. (2398-8835 (Electronic)). 30. Berlin DA, Gulick RM, Martinez FJ. Severe Covid-19. New England Journal of Medicine 2020; 383(25): 2451-60. 31. Iacobucci G. Covid-19: Severe infection in pregnancy significantly increases risks, study shows. BMJ 2022; 376: o480. 32. Mendez-Brito A, El Bcheraoui C, Pozo-Martin F. Systematic review of empirical studies comparing the effectiveness of non-pharmaceutical interventions against COVID-19. Journal of Infection 2021; 83(3): 281-93. 33. Threats IoMUFoM. Ethical and Legal Considerations in Mitigating Pandemic Disease: Workshop Summary. Strategies for Disease Containment. Washington (DC): National Academies Press (US), 2007. 34. Brooks SK, Webster RK, Smith LE, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. The Lancet 2020; 395(10227): 912-20. 35. Group TRC. Dexamethasone in Hospitalised Patients with Covid-19. New England Journal of Medicine 2020; 384(8): 693-704. 36. Gordon AA-OX, Mouncey PA-O, Al-Beidh F, et al. Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. (1533-4406 (Electronic)).
RkJQdWJsaXNoZXIy MTk4NDMw